IBDEI2K5 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43400,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,43400,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,43400,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,43401,0)
 ;;=E11.630^^167^2078^103
 ;;^UTILITY(U,$J,358.3,43401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43401,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,43401,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,43401,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,43402,0)
 ;;=E11.641^^167^2078^101
 ;;^UTILITY(U,$J,358.3,43402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43402,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,43402,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,43402,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,43403,0)
 ;;=E11.649^^167^2078^102
 ;;^UTILITY(U,$J,358.3,43403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43403,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,43403,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,43403,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,43404,0)
 ;;=E11.65^^167^2078^100
 ;;^UTILITY(U,$J,358.3,43404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43404,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,43404,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,43404,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,43405,0)
 ;;=G56.41^^167^2078^64
 ;;^UTILITY(U,$J,358.3,43405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43405,1,3,0)
 ;;=3^Causalgia Rt Upper Limb
 ;;^UTILITY(U,$J,358.3,43405,1,4,0)
 ;;=4^G56.41
 ;;^UTILITY(U,$J,358.3,43405,2)
 ;;=^5004030
 ;;^UTILITY(U,$J,358.3,43406,0)
 ;;=G56.42^^167^2078^63
 ;;^UTILITY(U,$J,358.3,43406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43406,1,3,0)
 ;;=3^Causalgia Lt Upper Limb
 ;;^UTILITY(U,$J,358.3,43406,1,4,0)
 ;;=4^G56.42
 ;;^UTILITY(U,$J,358.3,43406,2)
 ;;=^5004031
 ;;^UTILITY(U,$J,358.3,43407,0)
 ;;=I65.21^^167^2078^130
 ;;^UTILITY(U,$J,358.3,43407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43407,1,3,0)
 ;;=3^Occlusion & Stenosis Rt Carotid Artery
 ;;^UTILITY(U,$J,358.3,43407,1,4,0)
 ;;=4^I65.21
 ;;^UTILITY(U,$J,358.3,43407,2)
 ;;=^5007360
 ;;^UTILITY(U,$J,358.3,43408,0)
 ;;=I65.22^^167^2078^129
 ;;^UTILITY(U,$J,358.3,43408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43408,1,3,0)
 ;;=3^Occlusion & Stenosis Lt Carotid Artery
 ;;^UTILITY(U,$J,358.3,43408,1,4,0)
 ;;=4^I65.22
 ;;^UTILITY(U,$J,358.3,43408,2)
 ;;=^5007361
 ;;^UTILITY(U,$J,358.3,43409,0)
 ;;=I65.23^^167^2078^128
 ;;^UTILITY(U,$J,358.3,43409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43409,1,3,0)
 ;;=3^Occlusion & Stenosis Bil Carotid Arteries
 ;;^UTILITY(U,$J,358.3,43409,1,4,0)
 ;;=4^I65.23
 ;;^UTILITY(U,$J,358.3,43409,2)
 ;;=^5007362
 ;;^UTILITY(U,$J,358.3,43410,0)
 ;;=I63.131^^167^2078^71
 ;;^UTILITY(U,$J,358.3,43410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43410,1,3,0)
 ;;=3^Cereb Infarc d/t Rt Carotid Artery Embolism
 ;;^UTILITY(U,$J,358.3,43410,1,4,0)
 ;;=4^I63.131
 ;;^UTILITY(U,$J,358.3,43410,2)
 ;;=^5007308
 ;;^UTILITY(U,$J,358.3,43411,0)
 ;;=I63.132^^167^2078^69
 ;;^UTILITY(U,$J,358.3,43411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43411,1,3,0)
 ;;=3^Cereb Infarc d/t Lt Carotid Artery Embolism
 ;;^UTILITY(U,$J,358.3,43411,1,4,0)
 ;;=4^I63.132
 ;;^UTILITY(U,$J,358.3,43411,2)
 ;;=^5007309
 ;;^UTILITY(U,$J,358.3,43412,0)
 ;;=I63.231^^167^2078^72
 ;;^UTILITY(U,$J,358.3,43412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43412,1,3,0)
 ;;=3^Cereb Infarc d/t Rt Carotid Artery Occl/Sten
 ;;^UTILITY(U,$J,358.3,43412,1,4,0)
 ;;=4^I63.231
 ;;^UTILITY(U,$J,358.3,43412,2)
 ;;=^5007316
 ;;^UTILITY(U,$J,358.3,43413,0)
 ;;=I63.232^^167^2078^70
